Patents by Inventor Christian Clausen

Christian Clausen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230097342
    Abstract: The present invention relates to a cryoprotecting agent comprising a cryprotectant being one or more of: dextrin, dextran, isomaltooligosaccharide and derivatives thereof, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 30, 2023
    Inventors: Hans Berg ANDREASEN, Lars CHRISTENSEN, Kim NORDFJELD, Jeppe SKYTTE, Christian CLAUSEN, Bjorn HOLST
  • Patent number: 11484025
    Abstract: The present invention relates to a cryoprotecting agent comprising a cryprotectant being one or more of: dextrin, dextran, isomaltooligosaccharide and derivatives thereof, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: November 1, 2022
    Assignee: PHARMACOSMOS HOLDING A/S
    Inventors: Hans Berg Andreasen, Lars Christensen, Kim Nordfjeld, Jeppe Skytte, Christian Clausen, Bjorn Holst
  • Patent number: 9295762
    Abstract: The present application discloses that incorporation of dermatan sulfate and/or HA in composite scaffolds of certain polymers gives rise to a chondrogenic effect on chondrocytes resulting in formation of cartilage that resembles the natural ECM. This effect with dermatan sulfate as the primary additive has not previously been seen. The composites are formed by incorporation of dermatan sulfate finely dispersed particles optionally nanoparticles or as molecular dissolutions in a polymer matrix with no bonding between the DS and the matrix, providing the DS to the chondrocytes in an accessible non-crosslinked form.
    Type: Grant
    Filed: March 7, 2008
    Date of Patent: March 29, 2016
    Assignee: Coloplast A/S
    Inventors: Hanne Everland, Jacob Vange, Christian Clausen, Lene Feldskov Nielsen
  • Publication number: 20150320031
    Abstract: The present invention relates to a cryoprotecting agent comprising a cryprotectant being one or more of: dextrin, dextran, isomaltooligosaccharide and derivatives thereof, cryoprotecting and cryopreserved compositions, uses thereof, and methods of cryopreservation.
    Type: Application
    Filed: November 29, 2013
    Publication date: November 12, 2015
    Applicant: PHARMACOSMOS A/S
    Inventors: Hans Berg ANDREASEN, Lars CHRISTENSEN, Kim NORDFJELD, Jeppe SKYTTE, Christian CLAUSEN, Björn HOLST
  • Patent number: 8877246
    Abstract: The present invention provides for a composition, for augmentation and regeneration of living tissue in a subject, comprising a population of porous microparticles of a biodegradable polymer, one or more mammalian cell populations, and optionally, a biocompatible adhesive.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: November 4, 2014
    Assignee: Coloplast A/S
    Inventors: Hanne Everland, Peter Samuelsen, Jakob Vange, Christian Clausen, Monica Ramos Gallego
  • Patent number: 8721813
    Abstract: Bimetallic alloys prepared in a ball milling process, such as iron nickel (FeNi), iron palladium (FePd), and magnesium palladium (MgPd) provide in situ catalyst system for remediating and degrading nitro explosive compounds. Specifically, munitions, such as, 2,4,6-trinitrotoluene (TNT), cyclo-1,3,5-trimethylene-2,4,6-trinitramine (RDX), nitrocellulose and nitroglycerine that have become contaminants in groundwater, soil, and other structures are treated on site to remediate explosive contamination.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: May 13, 2014
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Christian Clausen, III, Cherie Geiger, Michael Sigman, Rebecca Fidler
  • Publication number: 20130251758
    Abstract: The present invention provides for a composition, for augmentation and regeneration of living tissue in a subject, comprising a population of porous microparticles of a biodegradable polymer, one or more mammalian cell populations, and optionally, a biocompatible adhesive.
    Type: Application
    Filed: January 11, 2013
    Publication date: September 26, 2013
    Applicant: COLOPLAST
    Inventors: HANNE EVERLAND, PETER SAMUELSEN, JAKOB VANGE, CHRISTIAN CLAUSEN, MONICA RAMOS GALLEGO
  • Patent number: 8092622
    Abstract: Bimetallic alloys prepared in a ball milling process, such as iron nickel (FeNi), iron palladium (FePd), and magnesium palladium (MgPd) provide in situ catalyst system for remediating and degrading nitro explosive compounds. Specifically, munitions, such as, 2,4,6-trinitrotoluene (TNT), cyclo-1,3,5-trimethylene-2,4,6-trinitramine (RDX), nitrocellulose and nitroglycerine that have become contaminants in groundwater, soil, and other structures are treated on site to remediate explosive contamination.
    Type: Grant
    Filed: June 4, 2009
    Date of Patent: January 10, 2012
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Christian Clausen, Cherie Geiger, Michael Sigman, Rebecca Fidler
  • Patent number: 8062442
    Abstract: Triacetone triperoxide (TATP) and other explosives of the peroxide family are safely degraded in situ. Nano and micron size metal particles in an elemental state include pure iron and magnesium or iron and magnesium particles that are mechanically alloyed with palladium and nickel. The metal particles are used in both the elemental state and in emulsions that are made from water, a hydrophobic solvent, such as corn oil, and a food-grade nonionic surfactant. The neat metals and emulsified zero valent metals (EZVM) safely degrade TATP with the major degradation product being acetone. The EZVM system absorbs and dissolves the TATP into the emulsion droplets where TATP degradation occurs. EZVM systems are ideal for degrading dry TATP crystals that may be present on a carpet or door entrance. Both the neat metal system and the emulsion system (EZVM) degrade TATP in an aqueous slurry.
    Type: Grant
    Filed: April 3, 2007
    Date of Patent: November 22, 2011
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Christian Clausen, III, Cherie L. Geiger, Michael Sigman, Rebecca Fidler
  • Publication number: 20110014267
    Abstract: An isolated, acellular biosynthetic cartilaginous matrix substantially devoid of synthetic biodegradable scaffold structure is provided. Through a method with the steps of a) contacting in vitro a population of chondrogenic cells with a synthetic biodegradable scaffold; b) culturing in vitro for a period of time said chondrogenic cells within said synthetic biodegradable scaffold so that the chondrogenic cells produce a biosynthetic cartilaginous matrix; c) substantially removing any antigen derived from said chondrogenic cells a matrix suitable of implantation into a living individual mammal, such as a human being is obtained.
    Type: Application
    Filed: March 2, 2009
    Publication date: January 20, 2011
    Inventors: Hanne Everland, Peter Samuelsen, Jakob Vange, Christian Clausen
  • Publication number: 20100322908
    Abstract: The present invention provides for a composition, for augmentation and regeneration of living tissue in a subject, comprising a population of porous microparticles of a biodegradable polymer, one or more mammalian cell populations, and optionally, a biocompatible adhesive.
    Type: Application
    Filed: March 2, 2009
    Publication date: December 23, 2010
    Inventors: Hanne Everland, Peter Samuelsen, Jakob Vange, Christian Clausen, Monica Ramos Gallego
  • Publication number: 20100034868
    Abstract: The present application discloses that incorporation of dermatan sulfate and/or HA in composite scaffolds of certain polymers gives rise to a chondrogenic effect on chondrocytes resulting in formation of cartilage that resembles the natural ECM. This effect with dermatan sulfate as the primary additive has not previously been seen. The composites are formed by incorporation of dermatan sulfate finely dispersed particles optionally nanoparticles or as molecular dissolutions in a polymer matrix with no bonding between the DS and the matrix, providing the DS to the chondrocytes in an accessible non-crosslinked form.
    Type: Application
    Filed: March 7, 2008
    Publication date: February 11, 2010
    Inventors: Hanne Everland, Jacob Vange, Christian Clausen, Nielsen Lene Feldskov
  • Publication number: 20090214614
    Abstract: The present invention provides for a method for tissue engineering by cell implantation that involves the use of a scaffold in situ at the site of a defect, where the therapeutic cells are fixed in place into the scaffold only once the scaffold is inserted at the site of the tissue defect, thereby locking not only the cells to the scaffold, but also the scaffold to the tissue defect. The invention also provides a kit of parts suitable for performing the method of the invention.
    Type: Application
    Filed: September 5, 2006
    Publication date: August 27, 2009
    Applicant: INTERFACE BIOTECH A/S
    Inventors: Hanne Everland, Christian Clausen, Kurt Osther
  • Patent number: 7518905
    Abstract: This invention provides novel high density memory devices that are electrically addressable permitting effective reading and writing, that provide a high memory density (e.g., 1015 bits/cm3), that provide a high degree of fault tolerance, and that are amenable to efficient chemical synthesis and chip fabrication. The devices are intrinsically latchable, defect tolerant, and support destructive or non-destructive read cycles. In a preferred embodiment, the device comprises a fixed electrode electrically coupled to a storage medium having a multiplicity of different and distinguishable oxidation states wherein data is stored in said oxidation states by the addition or withdrawal of one or more electrons from said storage medium via the electrically coupled electrode.
    Type: Grant
    Filed: November 2, 2005
    Date of Patent: April 14, 2009
    Assignees: The Regents of the University of California, North Carolina State University
    Inventors: David F Bocian, Werner G Kuhr, Jonathan Lindsey, Peter Christian Clausen, Daniel Tomasz Gryko
  • Publication number: 20080253999
    Abstract: The present invention relates to a method for propagating and/or differentiating mammalian cells, the method comprising exposing or co-culturing mammalian cells with one or more of periodontal ligament tissue, periodontal ligament proteins or factors derived from periodontal ligament tissue, to obtain cells having PDL characteristics and fulfilling at least one of the following: i) show periodontal characteristics as evidenced with Von Kossa method in which calcium phosphate deposits are stained brown to black, ii) show increased osteopontin and osteocalcin and at the same time decreased bone sialoprotein (bone sialoprotein II or BSP), iii) are capable of being implanted to repair and/or regenerate periodontal tissue, iv) are capable of repairing disorders such as paradentitis also called paradentosis, or periodontitis by healing of the gum line towards the teeth, and v) are accepted by the host without significant immune reaction or cell rejection.
    Type: Application
    Filed: September 28, 2006
    Publication date: October 16, 2008
    Inventors: Kurt Osther, Christian Clausen, Klaus Riskaer Pedersen
  • Publication number: 20080177125
    Abstract: Emulsified systems of a surfactant-stabilized, biodegradable water-in-solvent emulsion with bimetallic particles contained with the emulsion droplets are useful at removing PCBs from ex situ structures. The hydrophobic emulsion system draws PCBs through the solvent/surfactant membrane. Once inside the membrane, the PCBs diffuse into the bimetallic particles and undergo degradation. The PCBs continue to enter, diffuse, degrade, and biphenyl will exit the particle maintaining a concentration gradient across the membrane and maintaining a driving force of the reaction.
    Type: Application
    Filed: August 15, 2007
    Publication date: July 24, 2008
    Applicant: U.S.A as Represented by the Administrator of the National Aeronautics and Space Ad
    Inventors: Jacqueline Quinn, Christian Clausen, Cherie L. Geiger, Christina Coon, Laura B. Filipek, Cristina M. Berger, Kristen M. Milum
  • Patent number: 7271199
    Abstract: Emulsified systems of a surfactant-stabilized, biodegradable water-in-solvent emulsion with bimetallic particles contained with the emulsion droplets are useful at removing PCBs from ex situ structures. The hydrophobic emulsion system draws PCBs through the solvent/surfactant membrane. Once inside the membrane, the PCBs diffuse into the bimetallic particles and undergo degradation. The PCBs continue to enter, diffuse, degrade, and biphenyl will exit the particle maintaining a concentration gradient across the membrane and maintaining a driving force of the reaction.
    Type: Grant
    Filed: October 27, 2004
    Date of Patent: September 18, 2007
    Assignee: United States of America as Represented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Jacqueline Quinn, Christian Clausen, Cherie L. Geiger, Christina Coon, Cristina M. Berger, Laura B. Filipek, Kristen M. Milum
  • Publication number: 20070112243
    Abstract: PCBs are removed from contaminated media using a treatment system including catalyzed zero-valent metal particles and an organic hydrogen donating solvent. This treatment system provides a major benefit of eliminating PCBs in situ. The treatment system provides a “paste”-like system that is preferably applied to natural media and ex-situ structures.
    Type: Application
    Filed: August 7, 2006
    Publication date: May 17, 2007
    Applicant: United States of America as Represented by the Administrator of the National Aeronautics and Spac
    Inventors: Jacqueline Quinn, Kathleen Brooks, Cherie Geiger, Christian Clausen
  • Patent number: 7042755
    Abstract: This invention provides novel high density memory devices (FIG. 3) that are electrically addressable permitting effective reading and writing, that provide a high memory density (102), that provide a high degree of fault tolerance, and that are amenable to efficient chemical synthesis and chip fabrication. The devices arc intrinsically latchable, defect tolerant, and support destructive or non-destructive read cycles. In a preferred embodiment, the device comprises a fixed electrode electrically coupled to a storage medium having a multiplicity of different and distinguishable oxidation states wherein data is stored in said oxidation states by the addition or withdrawal of one or more electrons from said storage medium via the electrically coupled electrode.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: May 9, 2006
    Inventors: David F. Bocian, Werner G. Kuhr, Jonathan Lindsey, Peter Christian Clausen, Daniel Tomasz Gryko
  • Patent number: 7037946
    Abstract: A zero-valent metal emulsion is used to dehalogenate solvents, such as pooled dense non-aqueous phase liquids (DNAPLs), including trichloroethylene (TCE). The zero-valent metal emulsion contains zero-valent metal particles, a surfactant, oil and water. The preferred zero-valent metal particles are nanoscale and microscale zero-valent iron particles.
    Type: Grant
    Filed: October 31, 2003
    Date of Patent: May 2, 2006
    Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Debra R. Reinhart, Christian Clausen, Cherie L. Geiger, Jacqueline Quinn, Kathleen Brooks